NCT06063772Not yet recruitingPhase 4
Effect of Treatment of Pre-induction Hypertension on Hemodynamic Stability During Induction of General Anesthesia
Source: ClinicalTrials.gov · Last updated 8 Nov 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The purpose of this study is to determine if treatment of pre-induction hypertension with an intravenous short acting calcium channel antagonist will (1) reduce the magnitude and duration of blood pressure excursions outside of a pre-established normal range and (2) decrease the requirement for vasoactive medications during the period from induction of anesthesia until just prior to surgical incision.
- Status (registry)
- Not yet recruiting
- Phase (registry)
- Phase 4
- Study type
- Interventional
- Enrollment
- 64 (estimated)
- First submitted
- 8 May 2023
- Start date
- Jan 2025
- Primary completion date
- Dec 2025
- Lead sponsor
- University of California, San Diego
- Diseases
- High blood pressure
- NCT number
- NCT06063772
What you commit to
- Study type: Interventional · Phase 4
- Planned participants: 64
- From Jan 2025 to the primary completion date, Dec 2025
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Non-elective surgery.
- Treatment with another investigational drug or other intervention at the time of enrollment.
Other illness
- Presence of structural heart disease.
- Known acute or chronic kidney disease.
Other
- Known adverse reaction to clevidipine or any of its constituent parts.
- Pregnancy or lactation.
- Patients unable to consent for themselves.
- Incarcerated patients.
- Known defect in lipid metabolism.
Who the study is looking for
- Provision of signed and dated informed consent form
- Stated willingness to comply with all study procedures and availability for the duration of the study
- Any patient older than 18 years
- Scheduled for elective surgery requiring general anesthesia
- Presenting with hypertension during the pre-operative assessment (defined as either a systolic blood pressure \> 140 mmHg or a diastolic blood pressure \> 90 mmHg
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.